Higher positive cardiomyopathy genetic detection rates for whites

March 5, 2018

(HealthDay)—Compared with underrepresented minorities, white individuals have significantly higher positive detection rates and lower rates of inconclusive results on cardiomyopathy genetic testing, according to a study published online Feb. 28 in JAMA Cardiology.

Latrice G. Landry, Ph.D., from the U.S. Food and Drug Administration in Silver Spring, Md., and Heidi L. Rehm, Ph.D., from Brigham and Women's Hospital in Boston, conducted a cross-sectional analysis of the genetic panel results for 5,729 probands with a suspected diagnosis or family history of cardiomyopathy who had been referred for testing. The results were stratified into three categories: white (79.2 percent), Asian (6.1 percent), and underrepresented minorities (14.7 percent).

The researchers found that positive detection occurred in 29 percent of white individuals compared with 18.4 and 25 percent of underrepresented minorities and Asians, respectively (P < 0.001 and P = 0.12, respectively). Inconclusive results were seen in 24.6 percent of whites compared with 39.8 and 39.2 percent of underrepresented minorities and Asians, respectively (both P < 0.001).

"This clear disparity warrants further study to understand the gaps in usefulness, which may derive from a lack of clinical testing and research in underrepresented minority populations, in the hopes of improving genetic testing outcomes for in nonwhite groups," the authors write.

Explore further: MACE risk similar for white men, women, minorities after PCI

More information: Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Related Stories

MACE risk similar for white men, women, minorities after PCI

October 19, 2017
(HealthDay)—Women and minorities undergoing percutaneous coronary intervention (PCI) with everolimus-eluting stents have a risk of major adverse cardiac events (MACE) that is similar to that of white men, according to a ...

Genetics should inform care in noncompaction cardiomyopathy

February 14, 2018
(HealthDay)—Genetic stratification should play a role in clinical care of patients with noncompaction cardiomyopathy (NCCM), according to a study published in the Feb. 20 issue of the Journal of the American College of ...

Results from the PLATINUM DIVERSITY study presented

November 1, 2016
A dedicated stent study conducted exclusively in women and minority patients evaluated clinical outcomes within the era of contemporary PCI, comparing these results to a parallel cohort of white male patients. Although there ...

Greater racial, ethnic diversity of doctors found in Ob-Gyn

December 16, 2015
(HealthDay)—Among adult medical specialists, greater racial and ethnic diversity is found among obstetrician-gynecologists (ob-gyns), according to research published in the January issue of Obstetrics & Gynecology.

Why are minorities underrepresented in genetic cancer studies?

November 16, 2017
Socio-cultural and clinical factors as well as healthcare processes were important drivers of a woman's willingness to provide saliva specimens for future cancer research. This is according to Vanessa B. Sheppard of Virginia ...

Racial minorities less likely to see a doctor for psoriasis

December 13, 2017
Despite the fact that their disease may be more severe, a new study shows minorities are less likely than white Americans to see a doctor for psoriasis treatment. Researchers from the Perelman School of Medicine at the University ...

Recommended for you

Inflammation critical for preventing heart attacks and strokes, study reveals

September 19, 2018
Inflammation, long considered a dangerous contributor to atherosclerosis, actually plays an important role in preventing heart attacks and strokes, new research from the University of Virginia School of Medicine reveals.

Effective drug delivery to heart with tannic acid

September 18, 2018
Typical methods of drug delivery to the heart require surgical procedures involving incisions in the chest wall and bones. To efficiently treat cardiovascular and related vascular diseases without surgery, a KAIST research ...

Daily low-dose aspirin found to have no effect on healthy life span in older people

September 16, 2018
In a large clinical trial to determine the risks and benefits of daily low-dose aspirin in healthy older adults without previous cardiovascular events, aspirin did not prolong healthy, independent living (life free of dementia ...

Financial incentives for cholesterol control may be cost-effective

September 14, 2018
A program that offered financial incentives to both patients and their physicians to control low-density lipoproteins (LDL) cholesterol could be a cost-effective intervention for patients at high risk of cardiovascular disease ...

Apple's smartwatch has a heart monitor now

September 13, 2018
There will soon be another way to monitor your heart—from your wrist.

3-D virtual simulation gets to the 'heart' of irregular heartbeats

September 12, 2018
In a proof of concept study, scientists at Johns Hopkins report they have successfully performed 3-D personalized virtual simulations of the heart to accurately identify where cardiac specialists should electrically destroy ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.